Liver cancer rates have tripled since 1980, but UVA Health is offering a new, noninvasive treatment for the disease.

Monoclonal antibody therapy was approved for emergency use authorization by the FDA in November. The treatment is a combination of proteins given through an IV to patients who test positive for COVID-19.